Study supports TAVR for lower-risk patients

04/7/2013 | TCTMD.com

Transcatheter aortic valve replacement may be an appropriate treatment for severe aortic stenosis in patients who are at low or intermediate risk for surgery, according to a study published in the European Heart Journal. "Compared with patients at calculated risk, well-selected patients with STS-defined intermediate or low risk appear to have favorable clinical outcomes," the authors of the Swiss study wrote. U.S.-based physicians are hopeful TAVR indications can be broadened if data continue to support doing so, said Dr. William Suh of the University of California, Los Angeles.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA